Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 1/20 | 1.00 |
| ▸ | LMNA | P02545 | 4/20 | 0.69 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.69 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.69 |
| ▸ | MEN1 | O00255 | 1/20 | 0.69 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.69 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.66 |
| ▸ | DGKA | P23743 | 2/20 | 0.62 |
| ▸ | PRKCA | P17252 | 3/20 | 0.60 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.60 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.60 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.60 |
| ▸ | LPAR6 | P43657 | 1/20 | 0.59 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.59 |
| ▸ | LPAR4 | Q99677 | 1/20 | 0.59 |
| ▸ | LPAR5 | Q9H1C0 | 1/20 | 0.59 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.59 |
| ▸ | LPAR3 | Q9UBY5 | 1/20 | 0.59 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2115586 | 1.00 | MAPT (1.00) | MAPTLMNAKDM4EDUSP3MEN1 | |
| SCHEMBL141668 | 1.00 | MAPT (1.00) | MAPTLMNAKDM4EDUSP3MEN1 | |
| SCHEMBL1730481 | 1.00 | MAPT (1.00) | MAPTLMNAKDM4EDUSP3MEN1 | |
| SCHEMBL29649070 | 1.00 | MAPT (1.00) | MAPTLMNAKDM4EDUSP3MEN1 | |
| SCHEMBL180498 | 1.00 | MAPT (1.00) | MAPTLMNAKDM4EDUSP3MEN1 | |
| SCHEMBL629794 | 1.00 | MAPT (1.00) | MAPTLMNAKDM4EDUSP3MEN1 | |
| SCHEMBL26974 | 1.00 | MAPT (1.00) | MAPTLMNAKDM4EDUSP3MEN1 | |
| Propylene Glycol Monostearate SCHEMBL35521 | 1.00 | MAPT (1.00) | MAPTLMNAKDM4EDUSP3MEN1 | |
| SCHEMBL16458 | 1.00 | MAPT (1.00) | MAPTLMNAKDM4EDUSP3MEN1 | |
| SCHEMBL1173237 | 1.00 | MAPT (1.00) | MAPTLMNAKDM4EDUSP3MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8496939-B2 | An adjuvant is used in vaccine formulation, comprising a polymeric emulsifier Arlacel\" or ATLOX\"; stable, low viscosity | INTERVET INTERNATIONAL B.V. (NL) | 2013-07-30 | — | — | US | disclosed |
| EP-1367997-B1 | INJECTABLE WATER-IN-OIL EMULSIONS | INTERVET INT BV (NL) | 2009-08-05 | — | — | EP | disclosed |
| US-20080118538-A1 | OIL DISPERSION OF POWDER BEING SURFACE-TREATED WITH SPECIFIC HALF ESTER OIL, AND COSMETIC COMPOSITION CONTAINING THE SAME | MIYOSHI KASEI, INC. (JP) | 2008-05-22 | — | — | US | disclosed |
| EP-1881039-A1 | OIL DISPERSION OF POWDER BEING SURFACE-TREATED WITH SPECIFIC ACIDIC ESTER OIL, AND COSMETIC COMPOSITION CONTAINING THE SAME | Miyoshi Kasei, Inc. (JP) | 2008-01-23 | — | — | EP | disclosed |
| US-20040071716-A1 | Injectable water-in-oil emulsions | INTERVET INTERNATIONAL B.V. (NL) | 2004-04-15 | — | — | US | disclosed |
| EP-1367997-A1 | INJECTABLE WATER-IN-OIL EMULSIONS | Akzo Nobel N.V. (NL) | 2003-12-10 | — | — | EP | disclosed |
| WO-2002067899-A1 | INJECTABLE WATER-IN-OIL EMULSIONS | AKZO NOBEL N.V. (NL) | 2002-09-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040071716-A1 | Injectable water-in-oil emulsions | ALOX15, ALOX12, ALOX5 | MAPT 3856/4885LMNA 1361/4885KDM4E 2875/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.